Wrinkle

12

Review clinical trials related to Wrinkle. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides

Study Type: This is a multicenter, triple-blind, randomized controlled trial. Purpose: The goal of this clinical trial is to compare the effectiveness and safety of all commercially available Botulinum Neurotoxin Type A (BoNT-A) products for treating glabellar rhytides, commonly known as frown lines. This study is designed to provide comprehensive data on how these treatments compare in terms of improving frown lines and the duration of their effects. Main Questions the Study Aims to Answer: Which BoNT-A product provides the longest lasting effect on reducing glabellar rhytides? How do these products compare in terms of safety and the occurrence of side effects? Participant Tasks: Women aged 18 years or older with moderate to severe glabellar lines will participate. Participants will receive injections of a BoNT-A product into specific facial muscles. They will need to take weekly photographs using their smartphones to document changes in their frown lines. These photos will be securely sent to our research team for analysis. Participants will complete questionnaires at the start and end of the study to assess their satisfaction, quality of life, and any changes in their condition. Comparison Group: Researchers will compare participants receiving different types of BoNT-A products to see which one is more effective at reducing frown lines and maintaining these effects over time. The safety profiles of these products will also be compared to determine which has the fewest and least severe side effects. This study aims to fill important gaps in our understanding of Botulinum Neurotoxin Type A treatments, guiding more effective clinical decisions and improving patient outcomes.

Participants needed: 325
Trial details
Phase: Phase 4Age: 18+Biological sex: FemaleType: InterventionalSponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Updated: Jul 2, 2026Locations: 3
Eligibility criteria

Women aged 18 years or over, with moderate to severe glabellar lines [+3]

ASA Classification 3 or over [+5]

Status: Recruiting

Evaluation of Performance and Safety of INNEA and INNEA AQUA for the Treatment of Cheek and décolletage Wrinkles

A Post-Market, Single-arm, Confirmatory Interventional Clinical Investigation to evaluate the Performance and Safety of INNEA and INNEA AQUA for the treatment of cheek and décolletage wrinkles

Participants needed: 55
Trial details
Age: 35-65Biological sex: FemaleType: InterventionalSponsor: Innate srlUpdated: Apr 16, 2026Locations: 3
Eligibility criteria

Patient Informed consent form (ICF) signed; [+7]

Other - different - clinical conditions of the skin (i.e. rosacea,psoriasis, vit...

Status: Not yet recruiting

Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

Clinical trial to assess the real-world effectiveness of Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid (HA) gel for the treatment of mild-to-moderate facial aging, including volume loss, fine lines, and skin laxity, following treatment administered using routine clinical injection techniques over the course of 60 days.

Participants needed: 100
Trial details
Phase: Phase 4Age: 30-75Biological sex: AllType: InterventionalSponsor: Goldman, Butterwick, Fitzpatrick and GroffUpdated: Feb 19, 2026Locations: 1
Eligibility criteria

Adult subjects aged 30 to 75 years at the time of screening/baseline. [+7]

Prior use of injectable treatments to the face within the past 12 months, includ... [+17]

Status: Recruiting

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

Participants needed: 40
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Taumedika s.r.l.Updated: Jan 26, 2026Locations: 1
Eligibility criteria

all sexes [+3]

Pregnancy [+9]

Status: Recruiting

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System

Participants needed: 164
Trial details
Age: 30-60Biological sex: AllType: InterventionalSponsor: Bausch Health Americas, Inc.Updated: Dec 17, 2025Locations: 1
Eligibility criteria

Be an adult female or male, ≥30 - ≤60 years of age.

Participant is pregnant or breast feeding or trying to become pregnant for 3 mon...

Status: Not yet recruiting

Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Clinical trial to assess the effect of microdroplet hyaluronic acid filler to the cheek skin (SKINVIVE™, JUVÉDERM®, Irvine, CA) on skin quality in patients undergoing medical weight loss with GLP-1 therapy.

Participants needed: 24
Trial details
Phase: Phase 2Age: 25-50Biological sex: FemaleType: InterventionalSponsor: Goldman, Butterwick, Fitzpatrick and GroffUpdated: Oct 28, 2025Locations: 1
Eligibility criteria

Adult women aged 25-50 years. [+12]

The presence of severe facial skin aging (as defined by Modified Griffiths' Scal... [+19]

Status: Recruiting

AVAVA MIRIA General Use

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Participants needed: 200
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: AVAVA, Inc.Updated: Mar 11, 2025Locations: 1
Eligibility criteria

Male or female subjects between 18 to 70 years of age. [+18]

Skin pathology or condition that could interfere with evaluation of the study pr... [+21]

Status: Recruiting

The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles

Investigate the topical use of almond oil, almond oil augmented with 0.5% vitamin E, 0.025% tretinoin oil augmented with castor oil on the appearance of facial fine lines and wrinkles, pigmentation, hydration, trans-epidermal water loss, and sebum excretion rate.

Participants needed: 90
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Integrative Skin Science and ResearchUpdated: Aug 28, 2024Locations: 1
Eligibility criteria

Post-menopausal women of Fitzpatrick skin types 1, 2, and 3 [+1]

Individuals who are pregnant or breastfeeding [+11]

Status: Not yet recruiting

Efficacy and Safety of 675-nm Laser for Dorsal Hand Rejuvenation

This study aimed to evaluate efficacy and safety of 675-nm laser for dorsal hand rejuvenation in Thai patients. Twenty-six subjects aged 50 to 65 years diagnosed with wrinkle and solar lentigines on both dorsums of hands were included and treated with RedTouch for 3 times every 4 weeks. Then, they were follow up at 3 and 6 months after the final treatment. The measurement of 5-point Global Aesthetic Improvement Scale scores by physicians and subjects were conducted. Moreover, pigmentation level, wrinkle and texture were also recored using Antera. Elasticity was measured using Cutometer.

Participants needed: 26
Trial details
Age: 50-65Biological sex: AllType: InterventionalSponsor: Mahidol UniversityUpdated: Jul 8, 2024
Eligibility criteria

Subjects diagnosed with wrinkles and solar lentigines on both dorsum of hands

Pregnant or lactation [+5]

Status: Recruiting

The Effects of Almond on Facial Skin Collagen and Wrinkles

Investigate the effects of almond consumption on collagen production, elastin levels, wrinkles, and pigmentation among premenopausal women and postmenopausal women belonging to all Fitzpatrick skin types.

Participants needed: 60
Trial details
Age: 35-70Biological sex: FemaleType: InterventionalSponsor: Integrative Skin Science and ResearchUpdated: Jun 18, 2024Locations: 1
Eligibility criteria

Subjects 35 to 70 years of age of all skin types [+5]

Those with a nut allergy [+8]

Status: Recruiting

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.

Participants needed: 500
Trial details
Age: 20-65Biological sex: AllType: ObservationalSponsor: Global Aesthetics LLCUpdated: May 24, 2024Locations: 2
Eligibility criteria

Individuals of both genders. [+4]

Pregnant or breastfeeding female. [+19]

Status: Recruiting

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

Study evaluating the efficacy of a micro coring device for the treatment of moderate to severe check wrinkles

Participants needed: 35
Trial details
Age: 40-70Biological sex: AllType: InterventionalSponsor: Cytrellis Biosystems, Inc.Updated: Jan 4, 2019Locations: 6
Eligibility criteria

Males and females 40-70 years of age [+3]

Lesions suspicious for any malignancy or the presence of actinic keratosis, mela... [+14]